Shanghai Shyndec Pharmaceutical Co.,Ltd.’s Net Profit Dropped 39% in First Half of 2022

Shanghai Shyndec Pharmaceutical Co.,Ltd. (上海现代制药股份有限公司) (600420.SH) reported a net profit of 330 million yuan in the first half of 2022, down 39% year-on-year.

Meanwhile, the company posted 6.4 billion yuan in revenue, down 16.3% year-on-year.

At the end of the reporting period, it had 19.1 billion yuan in total assets and 8.6 billion yuan in total liabilities, with a liability-to-asset ratio of 45%.